January 30, 2015 9:01 AM ET


Company Overview of Epitomics, Inc.

Company Overview

Epitomics, Inc. is a biotechnology company that develops monoclonal antibody technologies for biomedical research, diagnostics, and therapeutics applications. It offers rabbit monoclonal, phospho specific, mouse tissue validated rabbit monoclonal, flow cytometry, and conjugated antibodies. The company also offers blocking peptides, cell lysates, secondary anti bodies, isotype controls, media and buffers, and purification products; LRRK2, thiophosphate, and PEG antibodies; and IHC products. In addition, it offers antibody sampler, ELISA, IHC, and purification kits; and EP Clones, a new line of antibodies for anatomical pathology. The company offers its products directly in the United States; ...

863 Mitten Road

Suite 103

Burlingame, CA 94010-1303

United States

Founded in 2002





Key Executives for Epitomics, Inc.

Chairman of the Board
Chief Financial Officer
Senior Vice President of Antibody Technology
Executive Vice President
Vice President of In Vitro Diagnostics
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Melanx Corporation United States
Phage International, Inc. United States
Medi-Physics, Inc. United States
Neodyne Biosciences Inc. United States
Seragen, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Epitomics, Inc., please visit www.epitomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.